APA (7th ed.) Citation

I, M., MM, M., M, C., J, M., SM, T., S, M., . . . AP, A. (2022). Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro. Frontiers in cellular and infection microbiology, 12, 840968. https://doi.org/10.3389/fcimb.2022.840968

Chicago Style (17th ed.) Citation

I, Morais, et al. "Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium Falciparum Development In Vitro." Frontiers in Cellular and Infection Microbiology 12 (2022): 840968. https://doi.org/10.3389/fcimb.2022.840968.

MLA (9th ed.) Citation

I, Morais, et al. "Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium Falciparum Development In Vitro." Frontiers in Cellular and Infection Microbiology, vol. 12, 2022, p. 840968, https://doi.org/10.3389/fcimb.2022.840968.